TNF and Alzheimer disease: Recently, the CSF levels of the inflammatory cytokine TNF-α have been found to be significantly higher in AD patients than in non-AD patients, which may lead to the activation of matrix metalloproteinases (MMP) and lead to opening of the blood-cerebrospinal fluid barrier (Tarkowski et al., 2003).